Supply Chain Fragility in Generic Insulin Markets
Sarah Jenkins · 5 min
The mRNA Revolution Moves to Pancreatic Cancer Trials
Following breakthrough data from the Copenhagen summit, three major labs are pivoting their oncology pipelines toward one of the deadliest cancers.
By Sarah Chen•8 min read•
From COVID platform to oncology bet
The mRNA platforms that rose to prominence during the pandemic are finding a second act in oncology.
Trial design
Each of the three programs takes a different route through the immunogenic maze.
Commercial stakes
Approval would validate a decade of platform investment.
Share
Related coverage
The Vanadium Brief
Every Monday morning, the definitive analysis of healthcare markets in your inbox.